title: Dasatinib in relapsed or plateau-phase multiple myeloma.
authors.affiliation: Division of Geriatrics and Nutritional Science, St Louis, MO 63110, USA. twildes@dom.wustl.edu
authors.forename: Tanya M
authors.initials: TM
authors.lastname: Wildes
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Procknow
authors.forename: Feng
authors.initials: F
authors.lastname: Gao
authors.forename: John F
authors.initials: JF
authors.lastname: Dipersio
authors.forename: Ravi
authors.initials: R
authors.lastname: Vij
mesh_terms: D000328:Adult; D000368:Aged; D000069439:Dasatinib; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000473:pathology; D009367:Neoplasm Staging; D011743:Pyrimidines / Q000627:therapeutic use*; D012008:Recurrence; D016879:Salvage Therapy; D015996:Survival Rate; D013844:Thiazoles / Q000627:therapeutic use*
chemical_list: D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib